Clinical mass spectrometry in neuroscience. Proteomics and peptidomics.

• In this review we discuss the merits and drawbacks with the use of proteomic and peptidomic strategies for identification of proteins and peptides in their multidimensional interactions in complex biological processes. The progress in proteomics and peptidomics during the last years offer us new challenges to study changes in the protein and peptide synthesis. These strategies also offer new tools to follow post-translational modifications and other disturbed chemical processes that may be indicative of pathophysiological alteration(s). Furthermore these techniques can contribute to improvements in the diagnosis and therapy of neurodegenerative diseases, such as Alzheimer's disease, and psychiatric diseases, as depression and post traumatic stress disorders. We also consider different practical aspects of the applications of mass spectrometry in clinical neuroscience, illustrated by example from our laboratories. The new proteomic and peptidomic strategies will further enable the progress for clinical neuroscience research.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Fysiologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Physiology (hsv//eng)

Nyckelord

Arteriosclerosis

diagnosis

metabolism

Brain Neoplasms

diagnosis

metabolism

Central Nervous System Diseases

diagnosis

metabolism

Cerebrospinal Fluid

chemistry

metabolism

Dementia

diagnosis

metabolism

Humans

Mass Spectrometry

Neurosciences

methods

Peptides

analysis

Proteins

analysis

Proteomics

methods

metabolism

Publikations- och innehållstyp

ref (ämneskategori)

for (ämneskategori)